Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...
The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...
Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...
The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the ...
It’s only been a few years since Arcutis began generating revenue, but the Thousand Oaks-based biotechnology company believes it is quickly becoming “an undisputed leader in medical dermatology,” and ...
A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...
This California high school features multi-hour labs that blend topics and the curriculum is tailored to students’ interests.
From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...
Baron Health Care Fund gained for the quarter and outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...
The surge in biotech breeding has brought new scrutiny to how policies handle risk related to genetic manipulation. The ...
Minister Nzimande’s address at BIO Africa-CPHIA 2025 is more than a policy speech—it is a strategic call to action for Africa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback